文献速递产科生殖医学

辅助生殖技术受孕双胞胎至5岁生长情况:一项全国生长队列研究

Growth of twins conceived using assisted reproductive treatments up to 5 years old: a national growth cohort.
PubMed 文献 · Hum Reprod · 2023-01-01

该队列研究纳入苏格兰1991至2009年间出生的13528例活产双胞胎(新鲜胚胎移植2792例、冻融胚胎移植556例、自然受孕10180例),比较三组在出生、6-8周及入学时的生长差异。结果显示,冻融胚胎移植双胞胎出生体重高于自然受孕和新鲜胚胎移植双胞胎,且至入学时仍更重,生长速度更快。

要点

  • 冻融胚胎移植双胞胎出生体重较自然受孕双胞胎高71g,较新鲜胚胎移植双胞胎高106g。
  • 足月双胞胎中冻融胚胎移植与自然受孕出生体重差异无统计学意义,早产双胞胎中冻融胚胎移植显著更高。
  • 至入学时,冻融胚胎移植双胞胎体重较自然受孕和新鲜胚胎移植双胞胎分别高614g和581g。

核心结论

  • 冻融胚胎移植双胞胎出生时更重、生长更快,至入学时仍比新鲜胚胎移植和自然受孕双胞胎更重。
  • 这与同队列单胎中三组入学时体重相近的观察不同。
  • 作者认为这些双胞胎结局需用更近期和全面的队列仔细评估。

研究设计与样本

  • 全国生长队列研究,纳入苏格兰1991至2009年间出生的13528例活产双胞胎,其中辅助生殖技术受孕新鲜胚胎移植2792例、冻融胚胎移植556例、自然受孕10180例。
  • 数据通过链接人类受精与胚胎学管理局辅助生殖技术登记数据、苏格兰发病率记录(SMR02)及苏格兰儿童健康项目数据集获得。
  • 结局数据在出生、6-8周(首次评估)及入学(4-7岁)时收集,采用线性混合模型或类似逻辑回归模型分析,并校正可用混杂因素。

主要发现

  • 出生体重:新鲜胚胎移植双胞胎较自然受孕对照低35g(95%CI:-53至-16g),冻融胚胎移植双胞胎较自然受孕对照高71g(95%CI:33至110g),较新鲜胚胎移植双胞胎高106g(95%CI:65至146g)。
  • 足月双胞胎(≥37周)中冻融胚胎移植与自然受孕出生体重差异无统计学意义(26g;95%CI:-30至82g),早产双胞胎中冻融胚胎移植显著更高(126g;95%CI:73至179g)。
  • 6-8周至入学期间,冻融胚胎移植双胞胎生长速度较自然受孕双胞胎快2.2g/周,较新鲜胚胎移植双胞胎快2.1g/周;出生至6-8周三组生长速度无显著差异。
  • 入学时,冻融胚胎移植双胞胎体重较自然受孕双胞胎高614g(95%CI:158至1070g),较新鲜胚胎移植双胞胎高581g(95%CI:100至1063g)。
  • 身长/身高及枕额围在各时间点均无显著差异。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 辅助生殖技术与自然受孕之间的差异虽反映真实辅助生殖技术效应,但这些效应可能部分通过两组间单/双卵双胎比例不同所介导。
  • 因数据不可用,无法探索卵性的中介效应。
  • 研究纳入的混杂变量仅限于数据集中可获得的变量。
  • 作者指出这些双胞胎结局需用更近期和全面的队列仔细评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do twins conceived through assisted reproductive treatments (ART) grow differently from naturally conceived (NC) twins in early life? SUMMARY ANSWER: Assessments at 6-8 weeks old and at school entry show that ART twins conceived from frozen embryo transfer (FET) grow faster than both NC twins and ART twins conceived from fresh embryo transfer (ET). WHAT IS KNOWN ALREADY: Singletons born from fresh ET grow more slowly in utero and in the first few weeks of life but then show postnatal catch-up growth by school age, compared to NC and FET babies. Evidence on early child growth of ART twins relative to NC twins is inconsistent; most studies are small and do not distinguish FET from fresh ET cycles. STUDY DESIGN, SIZE, DURATION: This cohort study included 13 528 live-born twin babies conceived by ART (fresh ET: 2792, FET: 556) and NC (10 180) between 1991 and 2009 in Scotland. The data were obtained by linking Human Fertilisation and Embryology Authority ART register data to the Scottish Morbidity Record (SMR02) and Scottish child health programme datasets. Outcome data were collected at birth, 6-8 weeks (first assessment), and school entry (4-7 years old) assessments. The primary outcome was growth, measured by weight at the three assessment points. Secondary outcomes were length (at birth and 6-8 weeks) or height (at school entry), BMI, occipital circumference, gestational age at birth, newborn intensive care unit admission, and growth rates (between birth and 6-8 weeks and between 6-8 weeks and school entry). PARTICIPANTS/MATERIALS, SETTING, METHODS: All twins in the linked dataset (born between 1991 and 2009) with growth data were included in the analysis. To determine outcome differences between fresh ET, FET, and NC twins, linear mixed models (or analogous logistic regression models) were used to explore the outcomes of interest. All models were adjusted for available confounders: gestational age/child age, gender, maternal age and smoking, Scottish Index of Multiple Deprivation, year of treatment, parity, ICSI, and ET stage. MAIN RESULTS AND THE ROLE OF CHANCE: In the primary birth weight models, the average birth weight of fresh ET twins was lower [-35 g; 95% CI: (-53, -16)g] than NC controls, while FET twins were heavier [71 g; 95% CI (33, 110) g] than NC controls and heavier [106 g; 95% CI (65, 146) g] than fresh ET twins. However, the difference between FET and NC twins was not significant when considering only full-term twins (≥37 weeks gestation) [26 g; 95% CI (-30, 82) g], while it was significantly higher in preterm twins [126 g; 95% CI (73, 179) g]. Growth rates did not differ significantly for the three groups from birth to 6-8 weeks. However, FET twins grew significantly faster from 6 to 8 weeks than NC (by 2.2 g/week) and fresh ET twins (by 2.1 g/week). By school entry, FET twins were 614 g [95% CI (158, 1070) g] and 581 g [95% CI (100, 1063) g] heavier than NC and fresh ET twins, respectively. Length/height and occipital frontal circumference did not differ significantly at any time point. LIMITATIONS, REASONS FOR CAUTION: Although the differences between ART and NC reflect the true ART effects, these effects are likely to be mediated partly through the different prevalence of mono/dizygotic twins in the two groups. We could not explore the mediating effect of zygosity due to the unavailability of data. The confounding variables included in the study were limited to those available in the datasets. WIDER IMPLICATIONS OF THE FINDINGS: Live-born twins from FET cycles are heavier at birth, grow faster than their fresh ET and NC counterparts, and are still heavier at school entry. This differs from that observed in singletons from the same cohort, where babies in the three conception groups had similar weights by school entry age. The results are reassuring on known differences in FET versus fresh ET and NC twin outcomes. However, FET twins grow faster and are consistently larger, and more ART twins depict catch-up growth. These may lead to an increased risk profile for non-communicable diseases in later life. As such, these twin outcomes require careful evaluation using more recent and comprehensive cohorts. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the EU H2020 Marie Sklodowska-Curie Innovative Training Networks (ITN) grant Dohartnet (H2020-MSCA-ITN-2018-812660). The authors have no competing interests to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kondowe FJM, Clayton P, Gittins M, et al. Growth of twins conceived using assisted reproductive treatments up to 5 years old: a national growth cohort. Hum Reprod. 2023. PMID: 36763679. doi:10.1093/humrep/dead018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。